• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于解释和报告阴性研究的一项提议。

A proposal for interpreting and reporting negative studies.

作者信息

Hauck W W, Anderson S

出版信息

Stat Med. 1986 May-Jun;5(3):203-9. doi: 10.1002/sim.4780050302.

DOI:10.1002/sim.4780050302
PMID:3526499
Abstract

An issue of continuing interest is the interpretation and reporting of 'negative' studies, namely studies that do not find statistically significant differences. The most common approach is the design-power method which determines, irrespective of the observed difference, what differences the study could have been expected to detect. We propose an alternative approach, the application of equivalence testing methods, where we define equivalence to mean that the actual difference lies within some specified limits. This approach, in contrast to the design-power approach, provides a way of quantifying (with p-values) what was actually determined from the study instead of saying what the study may or may not have accomplished with some degree of certainty (power). For example, a possible outcome of the equivalence testing approach is the conclusion at the 5 per cent level that two means (or proportions) do not differ by more than some specified amount. The equivalence testing approach applies to any study design. We illustrate the method with a cancer clinical trial and an epidemiologic case-control study. In addition, for those studies in which one cannot specify limits a priori, we propose the use of equivalence curves to summarize and present the study results.

摘要

一个持续受到关注的问题是“阴性”研究的解读与报告,即那些未发现具有统计学显著差异的研究。最常见的方法是设计效能法,该方法不考虑观察到的差异,而是确定研究预期能够检测到哪些差异。我们提出一种替代方法,即应用等效性检验方法,在此方法中,我们将等效性定义为实际差异落在某些指定限度内。与设计效能法相比,这种方法提供了一种(通过p值)量化从研究中实际确定内容的方式,而不是说明研究在某种程度上(效能)可能或不可能完成的事情。例如,等效性检验方法的一个可能结果是在5%的水平上得出两个均值(或比例)的差异不超过某个指定量的结论。等效性检验方法适用于任何研究设计。我们用一项癌症临床试验和一项流行病学病例对照研究来说明该方法。此外,对于那些无法事先指定限度的研究,我们建议使用等效性曲线来总结和呈现研究结果。

相似文献

1
A proposal for interpreting and reporting negative studies.关于解释和报告阴性研究的一项提议。
Stat Med. 1986 May-Jun;5(3):203-9. doi: 10.1002/sim.4780050302.
2
Some issues in the design and interpretation of 'negative' clinical studies.“阴性”临床研究的设计与解读中的一些问题。
Arch Intern Med. 1986 May;146(5):986-9.
3
Group sequential design and analysis of clinical equivalence assessment for generic nonsystematic drug products.仿制药非系统性药品临床等效性评估的序贯设计与分析
J Biopharm Stat. 2004 May;14(2):359-73. doi: 10.1081/BIP-120037186.
4
Inference of equivalence for the ratio of two normal means with unspecified variances.两个正态均值之比在方差未指定时的等效性推断。
J Biopharm Stat. 2014;24(6):1264-79. doi: 10.1080/10543406.2014.941990.
5
Sample size calculations for risk equivalence testing in pharmacoepidemiology.药物流行病学中风险等效性检验的样本量计算
J Clin Epidemiol. 2000 Dec;53(12):1268-74. doi: 10.1016/s0895-4356(00)00252-3.
6
Tests of equivalence and non-inferiority for diagnostic accuracy based on the paired areas under ROC curves.基于ROC曲线下配对面积的诊断准确性等效性和非劣效性检验。
Stat Med. 2006 Apr 15;25(7):1219-38. doi: 10.1002/sim.2358.
7
A confirmatory strategy for therapeutic equivalence trials.治疗等效性试验的一种确证性策略。
Int J Clin Pharmacol Ther. 1995 Jul;33(7):388-90.
8
Equivalence testing with dental clinical trials.牙科临床试验中的等效性检验。
J Dent Res. 2001 Jun;80(6):1513-7. doi: 10.1177/00220345010800060701.
9
An alternative approach to assess exchangeability of a test treatment and the standard treatment with normally distributed response.一种评估具有正态分布响应的试验治疗与标准治疗的可交换性的替代方法。
J Biopharm Stat. 2007;17(2):329-38. doi: 10.1080/10543400601177301.
10
Experimental design and statistical methods for classical and bioequivalence hypothesis testing with an application to dairy nutrition studies.用于经典和生物等效性假设检验的实验设计与统计方法及其在乳品营养研究中的应用
J Anim Sci. 2004;82 E-Suppl:E162-172. doi: 10.2527/2004.8213_supplE162x.

引用本文的文献

1
Replication of null results: Absence of evidence or evidence of absence?重复零结果:无证据还是缺乏证据?
Elife. 2024 May 13;12:RP92311. doi: 10.7554/eLife.92311.
2
Discontinuation and non-publication of heart failure randomized controlled trials: a call to publish all trial results.心力衰竭随机对照试验的终止与未发表:呼吁公布所有试验结果。
ESC Heart Fail. 2021 Feb;8(1):16-25. doi: 10.1002/ehf2.13099. Epub 2020 Nov 15.
3
Spontaneous dog osteoarthritis - a One Medicine vision.自发性犬骨关节炎——一种整体医学理念。
Nat Rev Rheumatol. 2019 May;15(5):273-287. doi: 10.1038/s41584-019-0202-1.
4
Conditional equivalence testing: An alternative remedy for publication bias.条件等价检验:一种纠正发表偏倚的替代方法。
PLoS One. 2018 Apr 13;13(4):e0195145. doi: 10.1371/journal.pone.0195145. eCollection 2018.
5
Publication bias and the pharmaceutical industry: the case of lamotrigine in bipolar disorder.发表偏倚与制药行业:以拉莫三嗪治疗双相情感障碍为例
Medscape J Med. 2008;10(9):211. Epub 2008 Sep 10.
6
Clopidogrel pre-treatment in stable angina: for all patients > 6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-8.稳定型心绞痛患者的氯吡格雷预处理:是在择期冠状动脉造影前>6小时对所有患者进行,还是仅在PCI前几分钟对血管造影选定的患者进行?一项随机多中心试验PRAGUE-8。
Eur Heart J. 2008 Jun;29(12):1495-503. doi: 10.1093/eurheartj/ehn169. Epub 2008 Apr 25.
7
Sample size determination for repeated measurements in bioequivalence test.生物等效性试验中重复测量的样本量确定
J Pharmacokinet Biopharm. 1997 Aug;25(4):507-13. doi: 10.1023/a:1025749210833.
8
Establishing equivalence between scaled measures of quality of life.建立生活质量量表测量结果之间的等效性。
Qual Life Res. 1996 Feb;5(1):20-6. doi: 10.1007/BF00435965.
9
Using statistical equivalence testing in clinical biofeedback research.在临床生物反馈研究中使用统计等效性检验。
Biofeedback Self Regul. 1996 Jun;21(2):105-19. doi: 10.1007/BF02284690.
10
Modeling and variable selection in epidemiologic analysis.流行病学分析中的建模与变量选择
Am J Public Health. 1989 Mar;79(3):340-9. doi: 10.2105/ajph.79.3.340.